Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000928464-15-000129
Filing Date
2015-12-30
Accepted
2015-12-30 17:00:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 mstxsch13damd1123115.htm SC 13D/A 113965
  Complete submission text file 0000928464-15-000129.txt   115911
Mailing Address C/O ICAHN ASSOCIATES HOLDING LLC 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES HOLDING LLC 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78541 | Film No.: 151314049
SIC: 2834 Pharmaceutical Preparations